Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review

F Nabizadeh, M Noori, S Rahmani… - Journal of Clinical …, 2023 - Elsevier
Background Although global vaccination against COVID-19 infection has its excellence,
potential side effects are yet of concern. Several lines of evidence have proposed ADEM …

Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease

J Dalmau, F Graus - The Lancet Neurology, 2023 - thelancet.com
Increased awareness of autoimmune encephalitis has led to two unintended consequences:
a high frequency of misdiagnoses and the inappropriate use of diagnostic criteria for …

Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

AJ Solomon, G Arrambide, WJ Brownlee… - The Lancet …, 2023 - thelancet.com
Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis—
many disorders can mimic the clinical manifestations and paraclinical findings of this …

[HTML][HTML] Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

O Corbali, T Chitnis - Frontiers in Neurology, 2023 - frontiersin.org
Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

[HTML][HTML] Central nervous system demyelinating diseases: Glial cells at the hub of pathology

VG Coutinho Costa, SES Araújo… - Frontiers in …, 2023 - frontiersin.org
Inflammatory demyelinating diseases (IDDs) are among the main causes of inflammatory
and neurodegenerative injury of the central nervous system (CNS) in young adult patients …

Aging in multiple sclerosis: From childhood to old age, etiopathogenesis, and unmet needs: A narrative review

N Capasso, E Virgilio, A Covelli, B Giovannini… - Frontiers in …, 2023 - frontiersin.org
Multiple sclerosis (MS) primarily affects adult females. However, in the last decades, rising
incidence and prevalence have been observed for demographic extremes, such as pediatric …

[HTML][HTML] MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity

SS Yandamuri, B Filipek, AH Obaid, N Lele… - JCI insight, 2023 - ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is an
inflammatory demyelinating CNS condition characterized by the presence of MOG …

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD

A Duchow, J Bellmann‐Strobl, T Friede… - Annals of …, 2024 - Wiley Online Library
Objective To investigate accumulation of disability in neuromyelitis optica spectrum disorder
(NMOSD) and myelin oligodendrocyte glycoprotein‐antibody‐associated disease (MOGAD) …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

A Al-Ani, JJ Chen, F Costello - Journal of Neurology, 2023 - Springer
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

T Kümpfel, K Giglhuber, O Aktas, I Ayzenberg… - Journal of …, 2024 - Springer
This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …